PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,032,986 | +4.7% | 35,510 | -0.9% | 0.00% | 0.0% |
| Q4 2023 | $987,061 | +24.6% | 35,815 | +1.3% | 0.00% | -20.0% |
| Q3 2023 | $792,261 | -42.9% | 35,353 | +3.7% | 0.01% | -37.5% |
| Q2 2023 | $1,386,725 | -15.6% | 34,097 | +0.6% | 0.01% | -27.3% |
| Q1 2023 | $1,642,358 | +29.5% | 33,905 | +2.0% | 0.01% | +22.2% |
| Q4 2022 | $1,268,427 | -24.2% | 33,231 | -0.4% | 0.01% | -25.0% |
| Q3 2022 | $1,674,000 | +27.1% | 33,352 | +1.4% | 0.01% | +33.3% |
| Q2 2022 | $1,317,000 | +2.3% | 32,880 | -4.7% | 0.01% | +28.6% |
| Q1 2022 | $1,287,000 | -12.4% | 34,484 | -6.6% | 0.01% | 0.0% |
| Q4 2021 | $1,470,000 | +3.9% | 36,912 | -2.9% | 0.01% | -12.5% |
| Q3 2021 | $1,415,000 | -14.0% | 38,016 | -2.3% | 0.01% | +33.3% |
| Q2 2021 | $1,645,000 | -3.5% | 38,919 | +8.1% | 0.01% | 0.0% |
| Q1 2021 | $1,705,000 | -22.2% | 36,018 | +0.3% | 0.01% | -25.0% |
| Q4 2020 | $2,192,000 | +26.9% | 35,923 | -2.8% | 0.01% | 0.0% |
| Q3 2020 | $1,728,000 | -9.9% | 36,954 | -2.2% | 0.01% | -11.1% |
| Q2 2020 | $1,918,000 | +20.3% | 37,794 | +5.7% | 0.01% | 0.0% |
| Q1 2020 | $1,595,000 | -12.2% | 35,759 | -5.5% | 0.01% | +28.6% |
| Q4 2019 | $1,817,000 | +48.6% | 37,825 | +4.6% | 0.01% | +40.0% |
| Q3 2019 | $1,223,000 | -25.4% | 36,163 | -0.7% | 0.01% | -16.7% |
| Q2 2019 | $1,639,000 | +32.7% | 36,415 | +11.0% | 0.01% | +20.0% |
| Q1 2019 | $1,235,000 | +20.7% | 32,804 | +10.1% | 0.01% | +25.0% |
| Q4 2018 | $1,023,000 | -27.5% | 29,808 | -0.8% | 0.00% | -20.0% |
| Q3 2018 | $1,412,000 | +41.9% | 30,037 | +1.8% | 0.01% | +66.7% |
| Q2 2018 | $995,000 | +43.4% | 29,496 | +15.1% | 0.00% | +50.0% |
| Q1 2018 | $694,000 | +53.9% | 25,631 | -5.1% | 0.00% | +100.0% |
| Q4 2017 | $451,000 | -15.2% | 27,009 | +1.6% | 0.00% | -50.0% |
| Q3 2017 | $532,000 | +40.4% | 26,587 | +28.6% | 0.00% | +100.0% |
| Q2 2017 | $379,000 | +87.6% | 20,682 | +1.0% | 0.00% | 0.0% |
| Q1 2017 | $202,000 | -3.3% | 20,480 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $209,000 | -99.9% | 19,125 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $268,642,000 | +99.9% | 19,175 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $134,405,000 | +5.0% | 19,146 | -3.4% | 0.00% | 0.0% |
| Q1 2016 | $128,000,000 | -80.1% | 19,824 | -0.0% | 0.00% | -66.7% |
| Q4 2015 | $642,000,000 | +121032.1% | 19,825 | -0.2% | 0.00% | +50.0% |
| Q3 2015 | $530,000 | -99.9% | 19,860 | +0.1% | 0.00% | -50.0% |
| Q2 2015 | $954,755,000 | +2.1% | 19,837 | +29.1% | 0.00% | 0.0% |
| Q1 2015 | $935,265,000 | +17.5% | 15,370 | 0.0% | 0.00% | +33.3% |
| Q4 2014 | $795,705,000 | +24.6% | 15,370 | +5.9% | 0.00% | 0.0% |
| Q3 2014 | $638,849,000 | +68.2% | 14,516 | -0.1% | 0.00% | +50.0% |
| Q2 2014 | $379,710,000 | +122.3% | 14,526 | +122.3% | 0.00% | +100.0% |
| Q1 2014 | $170,825,000 | +57.8% | 6,535 | +2.5% | 0.00% | 0.0% |
| Q4 2013 | $108,235,000 | – | 6,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
| Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
| RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
| GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
| Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
| SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
| SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
| Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
| Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |